A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Two Sigma Advisers, LP holds 1,976,000 shares of AMRN stock, worth $1.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,976,000
Previous 2,589,900 23.7%
Holding current value
$1.09 Million
Previous $1.79 Million 30.39%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.57 - $0.8 $349,922 - $491,120
-613,900 Reduced 23.7%
1,976,000 $1.24 Million
Q2 2024

Aug 14, 2024

SELL
$0.63 - $1.07 $140,112 - $237,968
-222,400 Reduced 7.91%
2,589,900 $1.79 Million
Q1 2024

May 15, 2024

BUY
$0.82 - $1.35 $69,452 - $114,342
84,698 Added 3.11%
2,812,300 $2.5 Million
Q4 2023

Feb 14, 2024

SELL
$0.66 - $0.91 $83,371 - $114,952
-126,321 Reduced 4.43%
2,727,602 $2.37 Million
Q3 2023

Nov 14, 2023

SELL
$0.85 - $1.43 $344,060 - $578,831
-404,777 Reduced 12.42%
2,853,923 $2.63 Million
Q2 2023

Aug 14, 2023

BUY
$1.12 - $1.49 $421,344 - $560,538
376,200 Added 13.05%
3,258,700 $3.88 Million
Q1 2023

May 15, 2023

BUY
$1.19 - $2.19 $1.24 Million - $2.29 Million
1,043,800 Added 56.77%
2,882,500 $4.32 Million
Q4 2022

Feb 14, 2023

BUY
$1.07 - $1.34 $1.18 Million - $1.47 Million
1,098,400 Added 148.37%
1,838,700 $2.22 Million
Q3 2022

Nov 14, 2022

BUY
$1.09 - $1.67 $478,074 - $732,462
438,600 Added 145.38%
740,300 $807,000
Q2 2022

Aug 15, 2022

BUY
$1.13 - $3.69 $169,047 - $552,024
149,600 Added 98.36%
301,700 $450,000
Q1 2022

May 16, 2022

BUY
$2.85 - $3.73 $259,882 - $340,127
91,187 Added 149.7%
152,100 $500,000
Q4 2021

Feb 14, 2022

BUY
$3.24 - $5.18 $3,781 - $6,045
1,167 Added 1.95%
60,913 $205,000
Q3 2021

Nov 15, 2021

SELL
$3.94 - $5.84 $3,546 - $5,256
-900 Reduced 1.48%
59,746 $305,000
Q2 2021

Aug 16, 2021

BUY
$4.26 - $6.5 $258,351 - $394,199
60,646 New
60,646 $266,000
Q1 2021

May 17, 2021

SELL
$5.03 - $8.8 $1.14 Million - $2 Million
-226,846 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$4.04 - $5.31 $416,980 - $548,061
103,213 Added 83.48%
226,846 $1.11 Million
Q3 2020

Nov 16, 2020

BUY
$3.64 - $7.76 $244,608 - $521,472
67,200 Added 119.08%
123,633 $520,000
Q2 2020

Aug 14, 2020

BUY
$4.78 - $8.26 $269,749 - $466,136
56,433 New
56,433 $391,000
Q4 2019

Feb 14, 2020

SELL
$13.94 - $24.12 $532,508 - $921,384
-38,200 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$13.89 - $23.16 $530,598 - $884,712
38,200 New
38,200 $579,000
Q1 2019

May 15, 2019

SELL
$12.61 - $22.33 $3.87 Million - $6.85 Million
-306,846 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$12.41 - $22.98 $3.4 Million - $6.29 Million
-273,767 Reduced 47.15%
306,846 $4.18 Million
Q3 2018

Nov 14, 2018

SELL
$2.45 - $16.27 $1.26 Million - $8.38 Million
-514,933 Reduced 47.0%
580,613 $9.45 Million
Q2 2018

Aug 14, 2018

BUY
$2.68 - $3.48 $18,224 - $23,664
6,800 Added 0.62%
1,095,546 $3.39 Million
Q1 2018

May 15, 2018

BUY
$2.99 - $4.44 $360,594 - $535,464
120,600 Added 12.46%
1,088,746 $3.28 Million
Q4 2017

Feb 14, 2018

BUY
$3.06 - $4.09 $1.5 Million - $2.01 Million
491,600 Added 103.16%
968,146 $3.88 Million
Q3 2017

Nov 14, 2017

BUY
$3.03 - $3.72 $1.44 Million - $1.77 Million
476,546
476,546 $1.67 Million

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $222M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.